Compile Data Set for Download or QSAR
Report error Found 146 Enz. Inhib. hit(s) with all data for entry = 6508
TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134531BDBM134531(US8846656, 23-I)
Affinity DataIC50: 0.5nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134505BDBM134505(US8846656, 21-D)
Affinity DataIC50: 0.5nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134518BDBM134518(US8846656, 21-AG)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134520BDBM134520(US8846656, 21-AI)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134523BDBM134523(US8846656, 21-AL)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134596BDBM134596(US8846656, 69-L)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134589BDBM134589(US8846656, 65-I)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134569BDBM134569(US8846656, 52-C)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134586BDBM134586(US8846656, 65-A)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134574BDBM134574(US8846656, 55-I)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134580BDBM134580(US8846656, 56-C)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134530BDBM134530(US8846656, 23-H)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134500BDBM134500(US8846656, 19-AF)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134512BDBM134512(US8846656, 21-R)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134577BDBM134577(US8846656, 55-M)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134519BDBM134519(US8846656, 21-AH)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134511BDBM134511(US8846656, 21-Q)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134582BDBM134582(US8846656, 56-F)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134524BDBM134524(US8846656, 21-AM)
Affinity DataIC50: 1nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134581BDBM134581(US8846656, 56-E)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134591BDBM134591(US8846656, 68-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134587BDBM134587(US8846656, 65-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134590BDBM134590(US8846656, 65-K)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134571BDBM134571(US8846656, 54-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134479BDBM134479(US8846656, 17-AM)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134529BDBM134529(US8846656, 23-G)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134546BDBM134546(US8846656, 29)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134498BDBM134498(US8846656, 19-AD)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134572BDBM134572(US8846656, 55-G)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134579BDBM134579(US8846656, 56-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134509BDBM134509(US8846656, 21-N)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134551BDBM134551(US8846656, 32-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134601BDBM134601(US8846656, 71-B)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134507BDBM134507(US8846656, 21-K)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134525BDBM134525(US8846656, 22-C)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134502BDBM134502(US8846656, 19-AI)
Affinity DataIC50: 2nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134544BDBM134544(US8846656, 28-B)
Affinity DataIC50: 3nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134562BDBM134562(US8846656, 41-G)
Affinity DataIC50: 3nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134576BDBM134576(US8846656, 55-L)
Affinity DataIC50: 3nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134545BDBM134545(US8846656, 28-D)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134593BDBM134593(US8846656, 69-H)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134497BDBM134497(US8846656, 19-AC)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134515BDBM134515(US8846656, 21-AB)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134588BDBM134588(US8846656, 65-H)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134573BDBM134573(US8846656, 55-H)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134490BDBM134490(US8846656, 19-F)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134470BDBM134470(US8846656, 17-G)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134594BDBM134594(US8846656, 69-I)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134517BDBM134517(US8846656, 21-AF)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

TargetC5a anaphylatoxin chemotactic receptor 1(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 134572BDBM134572(US8846656, 55-G)
Affinity DataIC50: 4nMAssay Description:Compounds were tested for their ability to inhibit C5a-mediated calcium mobilization using a stable cell line over expressing the human C5aR & the Ga...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/9/2015
Entry Details
US Patent

Displayed 1 to 50 (of 146 total ) | Next | Last >>
Jump to: